The Goldman Sachs Group Issues Pessimistic Forecast for Twist Bioscience (NASDAQ:TWST) Stock Price
Twist Bioscience (NASDAQ:TWST – Get Free Report) had its price target decreased by The Goldman Sachs Group from $55.00 to $48.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. The Goldman Sachs Group’s price objective would indicate a potential upside of 46.43% from […]
